A licensing company representing the <ENAMEX TYPE="ORGANIZATION">University</ENAMEX> of <ENAMEX TYPE="LOCATION">Pennsylvania</ENAMEX> added <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> to its lawsuit challenging a university faculty member over rights to Retin A acne medicine <ENAMEX TYPE="ORGANIZATION">University Patents Inc</ENAMEX> based in <ENAMEX TYPE="LOCATION">Westport Conn</ENAMEX> said it seeks <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> s profits from sales of Retin A estimated at 50 million a similar amount of punitive damages and the right to license Retin A elsewhere In <ENAMEX TYPE="ORGANIZATION">May University Patents</ENAMEX> filed a suit in federal court in <ENAMEX TYPE="LOCATION">Philadelphia</ENAMEX> against <ENAMEX TYPE="PERSON">Albert M Kligman</ENAMEX> a researcher and professor at the <ENAMEX TYPE="ORGANIZATION">University</ENAMEX> of <ENAMEX TYPE="LOCATION">Pennsylvania School</ENAMEX> of Medicine who developed Retin A in the 1960s to combat acne <ENAMEX TYPE="PERSON">Dr Kligman</ENAMEX> patented the medicine while employed by the <ENAMEX TYPE="ORGANIZATION">University</ENAMEX> but later licensed the Retin A to a division of <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> In <ENAMEX TYPE="ORGANIZATION">New Brunswick N J</ENAMEX> a <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> spokesman declined comment